市场调查报告书
商品编码
1410912
下一代定序市场:市场规模(按细分市场)、份额、监管、报销、预测(~2033 年)Next Generation Sequencers Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
新一代定序可以透过 DNA 片段化并以自动并行方式对这些片段进行定序来一次对整个基因组进行定序。新一代定序仪可用于全基因组定序、外显子定序、转录组定序(RNA 定序)和多基因组的标靶定序。
测试大量突变以製定个人化治疗策略现在已成为常态,并且越来越多地使用下一代定序来评估肿瘤活检中各种潜在的可靶向突变。
该报告深入探讨了全球下一代定序仪市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。
Next Generation Sequencers Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on Next Generation Sequencers market for the year 2020 and beyond. Next Generation Sequencers allows an entire genome to be sequenced at once by fragmenting DNA and sequencing those fragments in an automated, parallel manner. Next Generation Sequencers can be used for whole-genome sequencing, exome sequencing, transcriptome sequencing (RNA sequencing), and targeted sequencing of multigene panels.
It is now standard to test for a high number of mutations to personalize treatment decisions, use of Next Generation Sequencers that can evaluate tumor biopsies for a wide range of potentially targetable mutations is increasing.
This model includes High-throughput Next Generation Sequencers, Medium-throughput Next Generation Sequencers, Low-throughput Next Generation Sequencers.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Next Generation Sequencers and evolving competitive landscape:
2015- 2033
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Illumina Inc, Pacific Biosciences, Thermo Fisher Scientific Inc, Singular Genomics System Inc , and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable